Membraneless organelles, also called biomolecular condensates, are changing how scientists think about protein chemistry, various diseases and even the origin of life.

Generative artificial intelligence has become widely accepted as a tool that increases productivity. Yet the technology is ...

Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...

This paper presents an important advance in genetically encoded voltage imaging of the developing zebrafish spinal cord in vivo, capturing voltage dynamics in neuronal populations, single cells, and ...

As India ages, traditional diets aren't enough for optimal health after 50. Advances in nutrient delivery systems, like ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Insilico Medicine announced the nomination of ISM3830, its 23rd AI-empowered preclinical candidate (PCC) since 2021, in late November 2025, which demonstrated low toxicity risks, favorable ADME/PK ...

Amphix Bio today announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials and expand its pipeline to target ...

BioMarin Pharmaceutical Inc. and Amicus Therapeutics announced today that BioMarin has entered into a definitive agreement to acquire Amicus for $14.50 per share in an all-cash transaction for a total ...

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with ...

While “staffing your company” is imperative and often emphasized, many commanders centralize critical information, leading to ...

Before you buy stock in Netflix, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe ...